GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a major Indian pharmaceutical company with a global presence. Its share price depends on success in generic drug development, the launch of new drugs, and regulatory approvals in key markets such as the United States.
Share prices of companies in the market segment - Pharma holding
Dr. Reddy's is a major Indian pharmaceutical company with segments in generics, branded drugs, and pharmaceutical services. We classify it as a pharmaceutical holding company. The chart below shows the overall performance of this global sector.
Broad Market Index - GURU.Markets
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics, active pharmaceutical ingredients, and biosimilars. As a major foreign issuer, it is included in the GURU.Markets index. The chart below shows the performance of the US market. Compare it with the shares of this global pharmaceutical player.
Change in the price of a company, segment, and market as a whole per day
RDY - Daily change in the company's share price Dr. Reddys Laboratories
For Dr. Reddy's, an Indian pharmaceutical giant, daily price changes are a measure of its reaction to generic drug news and regulatory decisions. The graph of these fluctuations is unspectacular, but it is an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma holding
Dr. Reddy's Laboratories Limited is a major Indian pharmaceutical company. This chart shows the average daily volatility of the sector. Comparing this to RDY's performance, with its focus on generics and emerging markets, helps assess its unique risk profile.
Daily change in the price of a broad market stock, index - GURU.Markets
Dr. Reddy's Laboratories is an Indian pharmaceutical giant with a global presence. The pharmaceutical market in emerging markets offers significant potential, but also risks. The chart below shows the volatility in this sector, which helps assess how Dr. Reddy's fits into the global landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Dr. Reddys Laboratories
Dr. Reddy's is one of India's largest pharmaceutical manufacturers with a global presence. Its annual growth reflects both its success in the generics market and its strategy to develop its own innovative drugs.
Annual dynamics of market capitalization of the market segment - Pharma holding
Dr. Reddy's Laboratories Ltd. is a large Indian pharmaceutical company with a global presence. It produces both generic drugs and active pharmaceutical ingredients. The chart shows how its diversified portfolio and focus on emerging markets impact its performance relative to the global pharmaceutical industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Dr. Reddy's Laboratories is a major Indian pharmaceutical company. Its business includes both generic drug production and proprietary drug development. Its stock price reflects its success in global markets and the state of the Indian pharmaceutical industry.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Dr. Reddys Laboratories
The market capitalization of Dr. Reddy's, an Indian pharmaceutical company, depends on its product cycle. Monthly fluctuations on the chart reflect the success of new generic drug launches in the US market, sales data in emerging markets, and progress in developing its own innovative drugs.
Monthly dynamics of market capitalization of the market segment - Pharma holding
This chart shows the dynamics of the pharmaceutical sector. For Dr. Reddy's, one of India's largest generic drug manufacturers, this is the backdrop. Its movements reflect both competition in the generics market and its success in developing and launching its own drugs.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Dr. Reddy's Laboratories is a major Indian pharmaceutical company. As a manufacturer of generics and active ingredients, its business is less risky than that of innovative biotech companies. The chart below shows how much the company's performance depended on global healthcare trends and the specifics of the Indian market, rather than on sentiment in the US.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Dr. Reddys Laboratories
Shares of Dr. Reddy's, a major Indian pharmaceutical company, react weekly to news about the release of new generic drugs and regulatory decisions. FDA approval for the sale of a generic version of a popular drug in the US or, conversely, production issues can cause sharp price fluctuations.
Weekly dynamics of market capitalization of the market segment - Pharma holding
Dr. Reddy's shares, like those of other major generic drug makers, are responding to industry-wide events: patent expirations on popular drugs and pricing pressure. These factors create a general backdrop against which the company's performance can be compared.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Dr. Reddy's is an Indian pharmaceutical company. Its shares (ADR) are dependent on both its success in the global generics market and the state of the Indian economy. This chart allows you to assess how these factors influence its performance relative to the global market.
Market capitalization of the company, segment and market as a whole
RDY - Market capitalization of the company Dr. Reddys Laboratories
The Dr. Reddy's market capitalization chart is a financial valuation of one of India's largest pharmaceutical giants. It reflects the scale of its generics, active pharmaceutical ingredients, and branded drug business. The dynamics of this metric are a barometer of the global generics industry and the company's ability to compete in the US and emerging markets.
RDY - Share of the company's market capitalization Dr. Reddys Laboratories within the market segment - Pharma holding
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generic drugs and active pharmaceutical ingredients. Its share of the global pharmaceutical market capitalization reflects its scale and status as a key player in the generic drug market.
Market capitalization of the market segment - Pharma holding
Dr. Reddy's Laboratories is one of India's largest pharmaceutical companies with a global presence. The chart below shows the total market capitalization of all pharmaceutical holdings. It reflects the scale of the global pharmaceutical industry. In this area, Dr. Reddy's is a strong player in the production of generics and active ingredients.
Market capitalization of all companies included in a broad market index - GURU.Markets
India's pharmaceutical market is one of the largest in the world, and its players are visible on the overall chart. Dr. Reddy's Laboratories is a leading Indian pharmaceutical company with a global presence. Its market capitalization is determined by its portfolio of generics, branded drugs, and active pharmaceutical ingredients.
Book value capitalization of the company, segment and market as a whole
RDY - Book value capitalization of the company Dr. Reddys Laboratories
Dr. Reddy's book value is the tangible value of the Indian pharmaceutical giant. The chart reflects the value of its network of generic and active ingredient manufacturing plants, as well as its modern R&D centers. These are the physical assets that make high-quality medicines available worldwide.
RDY - Share of the company's book capitalization Dr. Reddys Laboratories within the market segment - Pharma holding
Dr. Reddy's Laboratories, a major Indian generics manufacturer, controls significant manufacturing assets. Its stake in the sector includes plants producing active pharmaceutical ingredients and finished dosage forms. This material base ensures its global supply.
Market segment balance sheet capitalization - Pharma holding
Dr. Reddy's Laboratories is a major Indian pharmaceutical company. Like any global drug manufacturer, their business relies on a network of manufacturing plants for active ingredients and finished dosage forms. The book value chart shows the value of this manufacturing infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
Dr. Reddy's assets include a large network of pharmaceutical manufacturing plants and research centers, primarily in India. The chart below shows the growth of this manufacturing base, which supplies affordable generic medications to markets around the world.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Dr. Reddys Laboratories
Dr. Reddy's owns generic manufacturing plants. Their market valuation adds a premium to their R&D pipeline and ability to bring complex generic drugs to market. The chart below shows how the market valued their scientific potential.
Market to book capitalization ratio in a market segment - Pharma holding
Dr. Reddy's Laboratories is a large Indian pharmaceutical company. It produces both generic and branded drugs. The chart shows how the market values its diversified product portfolio and manufacturing capacity relative to their book value.
Market to book capitalization ratio for the market as a whole
Dr. Reddy's Laboratories is one of India's largest pharmaceutical companies, producing both generic and branded drugs. Its valuation, relative to the market average, is a combination of its stable generic drug business and its in-house research and development capabilities. The market values its production capacity and scientific potential.
Debts of the company, segment and market as a whole
RDY - Company debts Dr. Reddys Laboratories
Dr. Reddy's Laboratories, a major Indian pharmaceutical company, manages its capital to fund the development of generics and new drugs, as well as international expansion. This chart shows how the company balances investment in R&D with maintaining financial stability, allowing it to compete in the global pharmaceutical market.
Market segment debts - Pharma holding
Dr. Reddy's Laboratories is one of India's largest pharmaceutical companies with a global presence. The company produces both generic and branded drugs, balancing stability and innovation. This chart shows how its financial strategy compares to other major players in the global pharmaceutical market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a large Indian pharmaceutical company producing generic drugs and active pharmaceutical ingredients. This chart shows its debt load. The business depends on the successful launch of new generics and competition in this segment. Increased pricing pressure or regulatory issues could impact profitability.
Market segment debt to market segment book capitalization - Pharma holding
Dr. Reddy's Laboratories is a large Indian pharmaceutical company producing both generic and branded drugs. To grow globally, it requires investment in R&D and production. The chart shows the overall debt burden in the pharmaceutical industry, which helps assess how Dr. Reddy's balances affordable medicines with innovation.
Debt to book value of all companies in the market
Dr. Reddy's is a major Indian pharmaceutical company. This chart shows the average debt level across the entire US market. It provides an interesting context for comparing the financial model of a major international generic drug manufacturer with overall trends in one of its key markets.
P/E of the company, segment and market as a whole
P/E - Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics, active pharmaceutical ingredients, and branded drugs. This chart shows how investors value one of the global generic drug market leaders. The company's performance depends on the successful launch of new generics in the US market and growth in emerging markets.
P/E of the market segment - Pharma holding
Dr. Reddy's Laboratories is one of India's leading pharmaceutical companies with a global presence. It produces a wide range of generics (analogs of brand-name drugs), active pharmaceutical ingredients, and innovative drugs. This chart shows the average rating for pharmaceutical holdings, allowing you to compare the Indian giant with its global competitors.
P/E of the market as a whole
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics and active pharmaceutical ingredients. This chart shows global healthcare trends. RDY's valuation depends on its ability to bring new generics to market, as well as the regulatory environment in the US and other key markets.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics (analogs of branded drugs) and active pharmaceutical ingredients. This chart reflects expectations for the global generics market. Its dynamics predict the company's success in introducing new drugs and competing in price wars.
%20P%2FE%20Dr.%20Reddys%20Laboratories&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Dr.-Reddys-Laboratories&v=1772655731492 "Chart of the company's future (projected) P/E Dr. Reddys Laboratories")
Future (projected) P/E of the market segment - Pharma holding
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company producing a wide range of generic drugs and active pharmaceutical ingredients. This chart shows the company's estimated future revenue in the context of the global pharmaceutical sector. It shows how investors assess its competitive position in the US and emerging markets.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-holding&v=1772655731516 "Future (projected) P/E graph of the market segment - Pharma holding")
Future (projected) P/E of the market as a whole
Dr. Reddy's Laboratories is a large Indian pharmaceutical company with a global presence, specializing in generics and active pharmaceutical ingredients. This graph of overall market expectations is less important for RDY than the dynamics of generic drug prices and the success of introducing new drugs to the US market. Their business has defensive qualities, as demand for drugs is stable.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772655731535 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing both generics (drug analogs) and original medications. The company has strong market positions in India, the US, and Russia. This chart shows the financial performance of a global pharmaceutical player with a balanced portfolio.
Profit of companies in the market segment - Pharma holding
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics and active pharmaceutical ingredients. This chart shows profitability in the global pharmaceutical industry. For RDY, it reflects global demand for affordable medications and their ability to compete in developed markets like the US.
Overall market profit
Dr. Reddy's Laboratories is a large Indian pharmaceutical company producing both generics (copies of drugs) and its own drugs. The company has strong positions in the Indian, US, and Russian markets. Its business is less cyclical than the industry, as demand for drugs is constant. This global earnings chart provides a backdrop for assessing prospects in the company's key markets.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing both generic and branded drugs. The profit forecast presented here reflects expectations from the launch of new generics in the US market, growth in emerging markets, and success in its own research. This is a look at the prospects for one of India's leading pharmaceutical companies.
%20profit%20of%20the%20company%20Dr.%20Reddys%20Laboratories&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Dr.-Reddys-Laboratories&v=1772655731713 "Graph of future (projected) profit of the company Dr. Reddys Laboratories")
Future (predicted) profit of companies in the market segment - Pharma holding
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generic drugs and active pharmaceutical ingredients. The profit forecast for this sector depends on the expiration of patents on original drugs and competition in the generics market. This chart shows analysts' expectations for the future of the global generic drug market, which is growing as the population ages.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-holding&v=1772655731762 "Graph of future (predicted) profits of companies in a market segment - Pharma holding")
Future (predicted) profit of the market as a whole
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics and active pharmaceutical ingredients. Its success depends on the expiration of patents on original drugs and global demand. The profit forecasts shown here influence healthcare budgets worldwide, which determine demand for generics.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772655731771 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a large Indian pharmaceutical company producing both generic and branded drugs. This chart shows how the market values its diversified revenue. This value depends on success in the competitive US generics market, as well as growth in emerging markets and new product launches.
P/S market segment - Pharma holding
Dr. Reddy's Laboratories is a large Indian pharmaceutical company producing a wide range of generics (analogs of brand-name drugs), active pharmaceutical ingredients, and innovative medications. This chart shows the industry average price-to-sales ratio. It helps understand how the market values Dr. Reddy's's global presence and its diversified product portfolio.
P/S of the market as a whole
Dr. Reddy's Laboratories is a major Indian pharmaceutical company with a global presence, producing both generic and branded drugs. Its success depends on the launch of new drugs and competition in the generic market. This chart reflects overall revenue estimates, allowing one to compare the prospects of this large pharmaceutical company in an emerging market with global trends.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics, active pharmaceutical ingredients, and innovative drugs. This chart shows how investors view the company's future sales. It reflects its ability to introduce new generics and compete in the global pharmaceutical market.
%20P%2FS%20Dr.%20Reddys%20Laboratories&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Dr.-Reddys-Laboratories&v=1772655731916 "The graph of the company's future (projected) P/S Dr. Reddys Laboratories")
Future (projected) P/S of the market segment - Pharma holding
Dr. Reddy's Laboratories is a large Indian pharmaceutical company with a global presence. It produces both generic (copy-cat) and branded drugs. This chart shows how investors view its diversified portfolio and its ability to compete in the global pharmaceutical market.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20holding&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-holding&v=1772655731982 "Future (projected) P/S market segment graph - Pharma holding")
Future (projected) P/S of the market as a whole
Dr. Reddy's Laboratories is a large Indian pharmaceutical company producing generics and active pharmaceutical ingredients. Their business depends on patent expirations and entry into new markets. This schedule of general market expectations affects Dr. Reddy's indirectly. Stable global economic growth supports healthcare systems, generating demand for more affordable generic medications.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772655732074 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a major Indian pharmaceutical company that produces both generics (analogs of original drugs) and active pharmaceutical ingredients. This chart shows sales volumes in the global pharmaceutical market. The company's revenue depends on the successful launch of new generics, particularly in the US market, and demand for its products in developing countries.
Sales of companies in the market segment - Pharma holding
Dr. Reddy's Laboratories is one of India's largest pharmaceutical companies with a global presence. They produce a wide range of generics (analogs of brand-name drugs), active pharmaceutical ingredients, and develop their own drugs. This chart shows how their revenue is distributed between North America, India, and other markets.
Overall market sales
Dr. Reddy's Laboratories is a major Indian pharmaceutical company. It manufactures and markets a wide range of medications, including generics, branded drugs, and active pharmaceutical ingredients, worldwide. This total revenue chart includes the global healthcare market, where Dr. Reddy's plays a vital role in ensuring access to medications.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics, active pharmaceutical ingredients, and branded drugs. This chart reflects global sales forecasts, which depend on the successful launch of new generics in the US market, growth in emerging markets, and the results of research into its own drugs.
%20sales%20of%20the%20company%20Dr.%20Reddys%20Laboratories&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Dr.-Reddys-Laboratories&v=1772655732352 "Schedule of future (projected) sales of the company Dr. Reddys Laboratories")
Future (projected) sales of companies in the market segment - Pharma holding
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics, active pharmaceutical ingredients, and branded medications. This chart shows forecasts for the entire global generics market. It reflects trends such as patent expirations on popular drugs, which present opportunities for Dr. Reddy's.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-holding&v=1772655732369 "Schedule of future (projected) sales of companies in the market segment - Pharma holding")
Future (projected) sales of the market as a whole
Dr. Reddy's Laboratories is a major Indian pharmaceutical company with a global presence, producing both generic and branded medications. This chart, reflecting the state of global healthcare, is important to the company. Economic stability in key markets, such as the US, ensures sustainable demand and solvency for the healthcare system.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772655732410 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Dr. Reddys Laboratories
Dr. Reddy's Laboratories is a major Indian pharmaceutical company. This chart shows its profitability. Profitability depends on sales of generics (non-patented versions of drugs) in developed markets like the US, as well as branded drugs in emerging markets. Successful patent challenges and efficient manufacturing are key to success.
Market segment marginality - Pharma holding
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics, active pharmaceutical ingredients, and branded drugs. Profitability depends on the successful launch of new generics and manufacturing efficiency. This chart shows operating results. A comparison with other pharmaceutical companies reveals its competitive position in the global market.
Market marginality as a whole
Dr. Reddy's Laboratories is a large Indian pharmaceutical company with a global presence, specializing in generics and active pharmaceutical ingredients. Its success depends on the introduction of new generics and competition. This overall profitability curve is largely unaffected by the specific cycles and pricing pressures in the pharmaceutical industry.
Employees in the company, segment and market as a whole
Number of employees in the company Dr. Reddys Laboratories
Dr. Reddy's Laboratories is one of India's largest pharmaceutical companies with a global presence. It produces a wide range of generics, active pharmaceutical ingredients, and branded medications. This chart shows the company's large international team of scientists, manufacturers, and marketers who make medicines more accessible to patients worldwide.
Share of the company's employees Dr. Reddys Laboratories within the market segment - Pharma holding
Dr. Reddy's Laboratories is a large Indian pharmaceutical company with a global presence, producing both generic and branded drugs. This chart illustrates its scale in the global pharmaceutical industry. It reflects the significant share of chemists, pharmacists, and clinical research specialists that Dr. Reddy's holds, particularly in India.
Number of employees in the market segment - Pharma holding
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics and active pharmaceutical ingredients for markets worldwide. This chart shows its extensive team of scientists, chemists, and manufacturing personnel who make medicines more accessible to millions of patients while successfully competing in the global pharmaceutical market.
Number of employees in the market as a whole
Dr. Reddy's Laboratories is an Indian pharmaceutical company that produces both generic and branded medications. Its success depends on the expiration of patents on original drugs and demand for affordable medications. The growth in overall employment shown in this chart supports healthcare systems around the world that are striving to control costs by using high-quality generics from Dr. Reddy's.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Dr. Reddys Laboratories (RDY)
Dr. Reddy's Laboratories is a large Indian pharmaceutical company. This chart reflects its model as a manufacturer of generic and branded drugs. The moderate capitalization per employee demonstrates the balance between scientific research and the need to maintain large production facilities to produce large volumes of drugs.
%20of%20the%20company%20Dr.%20Reddys%20Laboratories%20(RDY)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Dr.-Reddys-Laboratories-RDY&v=1772655732622 "Chart of market capitalization per employee (in thousands of dollars) of the company Dr. Reddys Laboratories (RDY)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma holding
Dr. Reddy's Laboratories is a large Indian pharmaceutical company, strong in both generics (copyright) production and proprietary drug development. This chart shows the industry average. It helps assess how the market values Dr. Reddy's hybrid model (generics + R&D) per employee compared to purely innovative companies.
%20by%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-holding&v=1772655732647 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma holding")
Market capitalization per employee (in thousands of dollars) for the overall market
Dr. Reddy's Laboratories is a major Indian pharmaceutical company producing generics and active pharmaceutical ingredients. In the pharmaceutical industry, this metric reflects the balance between production scale and research and development. It demonstrates how the market assesses a company's ability to compete in the global pharmaceutical market.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772655732679 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Dr. Reddys Laboratories (RDY)
Dr. Reddy's is a major Indian manufacturer of generics (copies of drugs). This chart illustrates the realities of the generics business. It's a highly competitive market, requiring both R&D (to be the first to copy a drug) and efficient, large-scale production. Profitability per employee here is lower than that of branded pharmaceuticals and depends on the speed of introducing new generics.
%20Chart%20Dr.%20Reddys%20Laboratories%20(RDY)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Dr.-Reddys-Laboratories-RDY&v=1772655732711 "Company Profit Per Employee (in thousands of dollars) Chart Dr. Reddys Laboratories (RDY)")
Profit per employee (in thousands of dollars) in the market segment - Pharma holding
Dr. Reddy's (RDY) is an Indian pharmaceutical giant specializing in generics. This chart shows the benchmark for "Pharma Holdings" (Generics). In this sector, the benchmark is moderate. This is not an "R&D business," but a "manufacturing business." Profit per employee depends on the efficiency of its factories and the speed of bringing generics to market.
%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-holding&v=1772655732737 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma holding")
Profit per employee (in thousands of dollars) for the market as a whole
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company. This labor productivity indicator helps assess the pharmaceutical industry. Profitability per employee here is the result of a combination of R&D efforts to create new drugs and the efficiency of its massive generic manufacturing plants.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772655732764 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Dr. Reddys Laboratories (RDY)
Dr. Reddy's Laboratories is a large Indian pharmaceutical company producing generic drugs and active pharmaceutical ingredients. This chart reflects efficiency in drug production and distribution. High revenue per employee is a result of production scale, global reach, and the ability to quickly bring generic drugs to market.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Dr.-Reddys-Laboratories-RDY&v=1772655732805 "Sales chart per company employee Dr. Reddys Laboratories (RDY)")
Sales per employee in the market segment - Pharma holding
Dr. Reddy's (RDY) is a major Indian manufacturer of generics (drug analogs) and active pharmaceutical ingredients. It's a business built on efficient production and R&D (copying). This chart shows how productive their low-cost manufacturing model is. It compares their revenue per employee with other pharmaceutical companies.
Sales per employee for the market as a whole
Dr. Reddy's Laboratories is an Indian pharmaceutical giant. Their business primarily consists of producing generic drugs for the global market, as well as developing their own products. This chart shows how efficiently their factories and R&D centers generate revenue in this highly competitive sector.
Short shares by company, segment and market as a whole
Shares shorted by company Dr. Reddys Laboratories (RDY)
Dr. Reddy's (RDY) is a major Indian pharmaceutical company, one of the world's leading producers of generics (analogs) and active pharmaceutical ingredients. This chart shows short bets. The rise in shorts may reflect concerns about pricing pressure in the US generics market or regulatory issues (FDA inspections) at their Indian plants.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Dr.-Reddys-Laboratories-RDY&v=1772655732891 "Short Shares Chart for the Company Dr. Reddys Laboratories (RDY)")
Shares shorted by market segment - Pharma holding
Dr. Reddy's (RDY) is an Indian pharmaceutical company and one of the largest producers of generic drugs, supplying products worldwide. This chart demonstrates the overall sentiment in the generics sector. It shows how many investors expect increased pricing pressure or regulatory challenges from the FDA for the entire industry.
Shares shorted by the overall market
Dr. Reddy's Laboratories (RDY) is a major Indian pharmaceutical company and one of the world's leading producers of generic drugs. This chart measures the overall level of market fear. When pessimism rises, RDY can take on an interesting look: on the one hand, it's a defensive sector (medications are always needed), but on the other, during a crisis, demand for cheaper generics can even increase.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Dr. Reddys Laboratories (RDY)
Dr. Reddy's is one of India's pharmaceutical giants. They produce both generics (copies of drugs) for the world and their own branded products. The chart shows when the market (above 70) is optimistic about the launch of new generics, or (below 30) when concerns about pricing pressure in the US or quality issues (FDA warnings) weigh on the stock.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Dr.-Reddys-Laboratories-RDY&v=1772655733010 "RSI 14 indicator chart for the company's stock Dr. Reddys Laboratories (RDY)")
RSI 14 Market Segment - Pharma holding
Dr. Reddy's Laboratories is a large Indian multinational pharmaceutical company. Their core business is the production and sale of generics (analogs of original drugs), active pharmaceutical ingredients (APIs), and specialty drugs. This chart shows the general sentiment in the generics and pharmaceutical holdings sector. It helps assess how the market views the industry as a whole.
RSI 14 for the overall market
Dr. Reddy's Laboratories is a large Indian pharmaceutical company specializing in the production of generics (analogs of expensive drugs) and active pharmaceutical ingredients. It is a defensive business. This market sentiment indicator shows that during times of panic (low values), investors seek stability. Demand for RDY's affordable generics, especially during a recession, remains high or even increases.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RDY (Dr. Reddys Laboratories)
Dr. Reddy's Laboratories is a major Indian pharmaceutical company specializing in the production of generics (drug analogs) and active pharmaceutical ingredients (APIs). This chart shows analyst consensus forecasts. Their targets depend on the successful launch of new generics in the US and growth in emerging markets such as India and Russia.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-RDY-Dr.-Reddys-Laboratories&v=1772655733185 "A chart showing analyst consensus forecasts for the expected stock price. RDY (Dr. Reddys Laboratories)")
The difference between the consensus estimate and the actual stock price RDY (Dr. Reddys Laboratories)
Dr. Reddy's is one of India's largest pharmaceutical companies, specializing in the production of generics (copies of drugs) and active pharmaceutical ingredients (APIs). This chart shows the difference between the consensus forecast and the price. It reflects analysts' confidence in RDY's ability to compete in the generics market and develop new markets.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-RDY-Dr.-Reddys-Laboratories&v=1772655733206 "A chart showing the difference between the consensus forecast and the actual stock price. RDY (Dr. Reddys Laboratories)")
Analyst consensus forecast for stock prices by market segment - Pharma holding
Dr. Reddy's Laboratories is one of India's largest pharmaceutical manufacturers, specializing in generics (copies of drugs) and active pharmaceutical ingredients (APIs). This chart shows analysts' overall expectations for the entire "big pharma" industry. It reflects whether experts believe the generics market is stable or whether they see pricing pressure.
Analysts' consensus forecast for the overall market share price
Dr. Reddy's Laboratories is a major Indian manufacturer of generics (analogues) and active pharmaceutical ingredients. Their business is providing affordable medications. Market expectations, as shown in this chart, influence their operations. During recessions (negative expectations), healthcare systems (and patients) around the world increasingly switch to cheaper generics.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Dr. Reddys Laboratories
Dr. Reddy's is one of India's largest pharmaceutical giants. Their business is diversified: they produce generics (copies of drugs) for the US market, active pharmaceutical ingredients (APIs), and branded drugs for emerging markets. This chart is a summary indicator of their hybrid model. It reflects the pricing environment in the US generic market and their growth in India.
AKIMA Market Segment Index - Pharma holding
Dr. Reddy's is an Indian pharmaceutical giant; the company is one of the world's largest producers of generic drugs (copies of medications), supplying them to the US, Indian, and Russian markets. This aggregate metric evaluates companies. The chart shows the sector average. This benchmark: how does Dr. Reddy's's large-scale (and low-margin) generic model differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
Dr. Reddy's is an Indian pharmaceutical giant, one of the world's largest producers of generic drugs (copies of drugs), with a strong presence in the US and emerging markets. This chart, which reflects the market average, provides a macro backdrop. It helps assess how Dr. Reddy's, which operates in the defensive sector, fits into the overall macroeconomic picture that impacts markets.
